Evidence map›Paper›PMID 33290386›Full record

ArticlePloS one2020

Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.

Lisa Hefele, Sengdavanh Syphan, Dalouny Xayavong, Anousin Homsana, Daria Kleine, Phetsavanh Chanthavilay, Phonethipsavanh Nouanthong, Kinnaly Xaydalasouk, Outavong Phathammavong, Somxay Billamay and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Lisa HefeleLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.ORCID 0000-0001-5449-9503
Sengdavanh SyphanLao Tropical and Public Health Institute, Vientiane, Lao PDR.
Dalouny XayavongLao Tropical and Public Health Institute, Vientiane, Lao PDR.
Anousin HomsanaLao Tropical and Public Health Institute, Vientiane, Lao PDR.
Daria KleineLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Phetsavanh ChanthavilayLao Tropical and Public Health Institute, Vientiane, Lao PDR.
Phonethipsavanh NouanthongLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Kinnaly XaydalasoukLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Outavong PhathammavongLuxembourg Development Cooperation Agency, Vientiane, Lao PDR.
Somxay BillamayChildren Hospital, Vientiane, Lao PDR.
Anonh XeuatvongsaExpanded Programme on Immunisation, Vientiane, Lao People's Democratic Republic.
Daniel ReinharzLao Tropical and Public Health Institute, Vientiane, Lao PDR.
Antony P BlackLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Claude P MullerLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao PDR.
Public Health Institute · USInstitut Pasteur du LaosLuxembourg Institute of Health · LURural Development Agency · LA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe timely administration of vaccines is considered to be important for both individual and herd immunity. In this study, we investigated the timeliness of the diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b (pentavalent) vaccine, scheduled at 6, 10 and 14 weeks of age in the Lao People's Democratic Republic. We also investigated factors associated with delayed immunization.

methods1162 children aged 8-28 months who had received the full course of the pentavalent vaccine at different levels of the health care system were enrolled. Vaccination dates documented in hospital records and/or immunisation cards were recorded. Age at vaccination and time intervals between doses were calculated. Predictors for timely completion with the pentavalent vaccine at 24 weeks were assessed by bivariate and multivariable analyses.

resultsSeveral discrepancies in dates between vaccination documents were observed. In general, vaccination with the pentavalent vaccine was found to be delayed, especially in health care settings below the provincial hospital level. Compared to the central hospital level, less participants who were vaccinated at the district/health center level received the third dose by 16 (48% at the central hospital level vs. 7.1% at the district and 12.4% at the health center level) and 24 weeks of age (94.4% at the central hospital level vs 64.6% at the district-outreach and 57.4% at the health center level) respectively. In logistic regression analyses, lower education level of the mother as well as vaccination by outreach service, were independently associated with delayed completion of vaccination.

conclusionWe observed a general delay of vaccination, especially at lower ranked facilities, which correlated with indicators of poor access to health services. This highlights the need for further improving health equity in rural areas. Age-appropriate vaccination should become a quality indicator for the national immunization programme. In addition, we recommend further training of the health care staff regarding the importance of reliable documentation of dates.

Indexed as

Child, PreschoolDiphtheriaDiphtheria-Tetanus-Pertussis VaccineEducational StatusFemaleHaemophilus InfectionsHaemophilus VaccinesHepatitis BHepatitis B VaccinesHospitalsHumansImmunizationImmunization ProgramsImmunization ScheduleInfantLaosDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesHepatitis B VaccinesVaccines, Combined

Identifiers

PMID33290386
PMCPMC7723256
OpenAlexW3111714631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.